Suppurative thrombophlebitis medical therapy

Suppurative thrombophlebitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Suppurative thrombophlebitis from other Diseases
Risk Factors
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Case Studies
Case #1
Suppurative thrombophlebitis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Suppurative thrombophlebitis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Suppurative thrombophlebitis medical therapy
CDC on Suppurative thrombophlebitis medical therapy
Suppurative thrombophlebitis medical therapy in the news
Blogs on Suppurative thrombophlebitis medical therapy
Directions to Hospitals Treating Suppurative thrombophlebitis
Risk calculators and risk factors for Suppurative thrombophlebitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The mainstay of therapy for suppurative thrombophlebitis is antimicrobial therapy. Empiric therapy includes anti-staphylococcal antibiotics plus antibiotics with coverage against enterobacteriaceae. The benefit of pharmacologic anticoagulation is uncertain in suppurative thrombophlebitis and is not routinely recommended.

Medical Therapy

Antimicrobial Regimens

• Treatment of suppurative thrombophlebitis

• 1. Bacterial pathogens

• 1.1 Gram-positive bacilli

• 1.1.1 Staphylococcus aureus

• 1.1.1.1 Methicillin-sensitive

• Preferred regimen: Nafcillin 2 g IV q4h OR Oxacillin 2 g IV q4h
• Alternative regimen: Cefazolin 2 g IV q8h OR Vancomycin 15 mg/kg q12h (trough levels 15-20 mcg/ml)

• 1.1.1.2 Methicillin-resistant

• Preferred regimen: Vancomycin 15 mg/kg q12h (trough levels 15-20 mcg/ml)
• Alternative regimen (1): Daptomycin 6-8 mg/kg/day IV q24h OR Linezolid 600 mg IV q12h
• Alternative regimen (2): Trimethoprim-sulfamethoxazole 20 mg TMP/kg/day IV q6hr

• 1.1.2 Coagulase-negative staphylococci

• 1.1.2.1 Methicillin-sensitive

• Preferred regimen:
• Alternative regimen:

• 1.1.2.2 Methicillin-resistant

• Preferred regimen:
• Alternative regimen:

• 1.1.3 Enterococcus faecalis & Enterococcus faecium

• 1.1.3.1 Ampicillin-sensitive

• Preferred regimen:
• Alternative regimen:

• 1.1.3.2 Ampicillin-resistant & Vancomycin-sensitive

• Preferred regimen:
• Alternative regimen:

• 1.1.3.3 Ampicillin-resistant & Vancomycin-resistant

• Preferred regimen:
• Alternative regimen:

• 1.2 Gram-negative bacilli

• 1.2.1 Escherichia coli & Klebsiella spp.

• 1.2.1.1 ESBL negative

• Preferred regimen:
• Alternative regimen:

• 1.2.1.2 ESBL negative

• Preferred regimen:
• Alternative regimen:

• 1.2.2 Enterobacter spp. & Serratia marcescens

• Preferred regimen:
• Alternative regimen:

• 1.2.3 Acinetobacter spp.

• Preferred regimen:
• Alternative regimen:

• 1.2.4 Stenotrophomonas maltophilia

• Preferred regimen:
• Alternative regimen:

• 1.2.5 Pseudomonas aeruginosa

• Preferred regimen:
• Alternative regimen:

• 1.2.6 Burkholderia cepacia

• Preferred regimen:
• Alternative regimen:

• 2. Fungal pathogens

• 2.1 Candida spp.

• Preferred regimen:
• Alternative regimen:

• 3. Uncommon pathogens

• 3.1 Corynebacterium jeikeium

• Preferred regimen:
• Alternative regimen:

• 3.2 Chryseobacterium (Flavobacterium) spp.

• Preferred regimen:
• Alternative regimen:

• 3.3 Ochrobacterium anthropi

• Preferred regimen:
• Alternative regimen:

• 3.4 Malassezia furfur

• Preferred regimen:
• Alternative regimen:

• 3.5 Mycobacterium species

• Preferred regimen:
• Alternative regimen:

References

Template:WikiDoc Sources